Unbound Medicine and Wiley-Blackwell Announce Partnership with Launch of Evidence Central™
Charlottesville, VA, December 15, 2009—Unbound Medicine, a leader in knowledge management solutions for healthcare, today announced the launch of Evidence Central™, an integrated, evidence-based solution, with content from its partner, Wiley-Blackwell, the scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, Inc. Evidence Central supports effective medical practice through delivery of the latest research and guidelines to mobile devices and the web.
Evidence Central is designed to answer evidence-based questions and keep clinicians up to date by delivering the latest scientific research and literature on a daily basis. Evidence Central includes up-to-date review abstracts of therapeutic interventions in Cochrane Abstracts, clinical guidelines and supporting summaries in Evidence-Based Medicine Guidelines, daily relevant evidence reviews in EE+ POEMs (Patient-Oriented Evidence that Matters from Essential Evidence Plus), and literature citations, abstracts, and links to full text in MEDLINE Journals. Powered by the Unbound™ Platform, this clinically-useful information is easily accessible on the web or mobile device platforms including iPhone™, iPod touch®, BlackBerry®, Android™, Windows Mobile®, and Palm®.
Clinicians can search Cochrane Abstracts summaries detailing the validity of research findings on a medical topic, then use Cross Links to connect to clinical guidelines and supporting information, including images and videos. Unbound Medicine’s MEDLINE Journals feature connects these entries to journal abstracts and provides alerts for new journal articles as they are published. Daily EE+ POEMs are organized for easy application in practice and are available in an archive for future reference.
“With Evidence Central, our resources are fully integrated with one another, making it easy for clinicians to efficiently identify clinically meaningful research findings and apply them to patient care,” said Shawn Morton, journals publishing director, Medicine, Americas at Wiley-Blackwell. “Unbound Medicine’s advanced mobile technology with download to all the popular mobile platforms and simple over-the-air synchronization ensures availability of the latest information at the point of care or wherever it’s needed.”
“Medicine is moving toward evidence-based practice,” said Bill Detmer, MD, president of Unbound Medicine. “The Cochrane Abstracts, Evidence-Based Medicine Guidelines, and EE+ POEMs are recognized worldwide as expert leaders in the analysis and communication of evidence-based medicine. We are pleased to partner with Wiley-Blackwell to offer resources that can have a powerful impact on the quality of healthcare.”
For more information, visit evidence.unboundmedicine.com.
About Unbound Medicine
Unbound Medicine, Inc. develops next-generation knowledge management systems for healthcare. The company’s handheld, wireless, and web-based technology platform and its information architecture services provide healthcare professionals with advanced systems for acquiring, managing, and sharing knowledge. Additional information is available at www.unboundmedicine.com.
Founded in 1807, John Wiley & Sons, Inc., has been a valued source of information and understanding for 200 years, helping people around the world meet their needs and fulfill their aspirations. Since 1901, Wiley and its acquired companies have published the works of more than 350 Nobel laureates in all categories: Literature, Economics, Physiology/Medicine, Physics, Chemistry and Peace.
Wiley’s core businesses include scientific, technical, medical and scholarly (STMS) journals, encyclopedias, books and online products and services; professional/trade books, subscription products, training materials, online applications and websites; and educational materials for undergraduate and graduate students and lifelong learners. Wiley’s global headquarters are located in Hoboken, N.J., with operations in the U.S., Europe, Asia, Canada and Australia. The company’s website can be accessed at www.wiley.com. The company is listed on the New York Stock Exchange under the symbols JWa and JWb.
Wiley-Blackwell is the international STMS publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world’s leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit www.wileyblackwell.com or www.interscience.wiley.com.